ALEXANDER PORUCZNIK: Open Payments
NPI 1952943649 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 47 payments from 10 companies in 2025. Trend: 2023 $806 · 2024 $804 · 2025 $828
Food & beverage: $819Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $270 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| Janssen Biotech, Inc. | 4 | $93 |
| UCB, Inc. | 4 | $91 |
| LEO Pharma Inc. | 4 | $90 |
| GENZYME CORPORATION | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| Organon LLC | 3 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, Bimzelx, ANZUPGO, EBGLYSS, RINVOQ, Winlevi.
Industry payments across IN — which companies pay providers there.
